期刊
JOURNAL OF MOLECULAR GRAPHICS & MODELLING
卷 41, 期 -, 页码 61-67出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jmgm.2013.02.003
关键词
Azaoxoisoaporphine derivatives; Alzheimer's disease; AChE inhibitors; A beta aggregation; 3D-QASR; CoMFA
类别
资金
- Specialized Research Fund for the Doctoral Program of Higher Education [20110171110051]
- Natural Science Foundation of China [21172272, 21103234]
- Fundamental Research Funds for the Central Universities [11ykzd05]
- Natural Science Foundation of Guangdong Province [S2011030003190]
- International S&T Cooperation Program of China [2010DFA34630]
In the present study, a series of novel azaoxoisoaporphine derivatives were reported and their inhibitory activities toward acetylcholinesterase (AChE), butyrylcholinesterase (BuChE), and A beta aggregation were evaluated. The new compounds remained high inhibitory potency on A beta aggregation, with inhibitory activity from 29.42% to 89.63% at a concentration of 10 mu M, but had no action on AChE or BuChE, which was very different from our previously reported oxoaporphine and oxoisoaporphine derivatives. By 3D-QSAR studies, we constructed a reliable CoMFA model (q(2) = 0.856 and r(2) = 0.986) based on the inhibitory activities toward AChE and discovered key information on structure and anti-AChE activities among the azaoxoisoaporphine, oxoaporphine, and oxoisoaporphine derivatives. The model was further confirmed by the test-set validation (q(2) = 0.873, r(2) = 0.937, and slope k = 0.902) and Y-randomization examination. The statistically significant and physically meaningful 3D-QSAR/CoMFA model provided better insight into understanding the inhibitory behaviors of those chemicals, which may provide useful information for the rational molecular design of azaoxoisoaporphine derivatives anti-AChE and anti-AD agents. (C) 2013 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据